Cognizant (CTSH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Werte in diesem Artikel
For the quarter ended June 2025, Cognizant (CTSH) reported revenue of $5.25 billion, up 8.1% over the same period last year. EPS came in at $1.31, compared to $1.17 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $5.19 billion, representing a surprise of +1.01%. The company delivered an EPS surprise of +3.97%, with the consensus EPS estimate being $1.26.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Cognizant performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Revenues- Health Sciences: $1.55 billion compared to the $1.61 billion average estimate based on two analysts. The reported number represents a change of +6.2% year over year.Revenues- Communications, Media and Technology: $841 million versus the two-analyst average estimate of $826.36 million. The reported number represents a year-over-year change of +3.1%.Revenues- Products and Resources: $1.31 billion versus $1.25 billion estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +16% change.Revenues- Financial services: $1.55 billion compared to the $1.52 billion average estimate based on two analysts. The reported number represents a change of +6.9% year over year.View all Key Company Metrics for Cognizant here>>>Shares of Cognizant have returned -6.9% over the past month versus the Zacks S&P 500 composite's +3.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.#1 Semiconductor Stock to Buy (Not NVDA)The incredible demand for data is fueling the market's next digital gold rush. As data centers continue to be built and constantly upgraded, the companies that provide the hardware for these behemoths will become the NVIDIAs of tomorrow.One under-the-radar chipmaker is uniquely positioned to take advantage of the next growth stage of this market. It specializes in semiconductor products that titans like NVIDIA don't build. It's just beginning to enter the spotlight, which is exactly where you want to be.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cognizant Technology Solutions Corporation (CTSH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Cognizant und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Cognizant
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Cognizant
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Cognizant Corp.
Analysen zu Cognizant Corp.
Datum | Rating | Analyst | |
---|---|---|---|
03.05.2019 | Cognizant Hold | Needham & Company, LLC | |
03.05.2019 | Cognizant Perform | Oppenheimer & Co. Inc. | |
07.02.2019 | Cognizant Outperform | BMO Capital Markets | |
02.11.2018 | Cognizant Market Perform | BMO Capital Markets | |
08.02.2018 | Cognizant Overweight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
07.02.2019 | Cognizant Outperform | BMO Capital Markets | |
02.11.2018 | Cognizant Market Perform | BMO Capital Markets | |
08.02.2018 | Cognizant Overweight | Barclays Capital | |
08.02.2018 | Cognizant Strong Buy | Needham & Company, LLC | |
08.11.2017 | Cognizant Buy | Pivotal Research Group |
Datum | Rating | Analyst | |
---|---|---|---|
03.05.2019 | Cognizant Hold | Needham & Company, LLC | |
03.05.2019 | Cognizant Perform | Oppenheimer & Co. Inc. | |
10.01.2017 | Cognizant Technology Solutions Hold | Loop Capital | |
30.09.2016 | Cognizant Technology Solutions Hold | Argus Research Company | |
09.09.2016 | Cognizant Technology Solutions Neutral | Wedbush Morgan Securities Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
02.03.2009 | Cognizant Technology underperform | Wachovia Securities, LLC | |
18.12.2006 | Update Cognizant Technology Solutions Corp.: Under | HSBC Securities |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Cognizant Corp. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen